1788
G. Sabitha et al.
LETTER
(8) Schelecht, M. F.; Kim, H.-J. Tetrahedron Lett. 1985, 26,
Table Allylation of Cyclic Anhydrides and Ring-Closing Metathe-
sis of Lactonedienes
127.
(9) Otsubo, K.; Inanaga, J.; Yamaguchi, M. Tetrahedron Lett.
1986, 27, 5763.
Entry Cyclic anhydride Lactone diene
Spirolactone
4
5
7
(10) Mandal, A. K.; Mahajan, S. W. Synthesis 1991, 311.
(11) (a) Paquette, L. A.; Owen, D. R.; Bibart, R. T.; Seekamp, C.
K.; Kahane, A. L.; Lanter, J. C.; Corral, M. A. J. Org. Chem.
2001, 66, 2828. (b) Iwahama, T.; Sakaguchi, S.; Ishii, Y.
Chem. Comm. 2000, 613.
a
(12) For some recent reviews on olefin metathesis, see:
(a) Trinca, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34,
18. (b) Fürstner, A. Angew. Chem. Int. Ed. 2000, 39, 3013.
(c) Maier, M. E. Angew. Chem. Int. Ed. 2000, 39, 2073.
(d) Fürstner, A. Synlett 1999, 371. (e) Wright, D. L. Curr.
Org. Chem. 1999, 3, 211. (f) Grubbs, R. H.; Chang, S. J.
Chem. Soc., Perkin Trans. 1 1998, 54, 4413. (g) Amstrong,
S. K.; Chang, S. J. Chem. Soc., Perkin Trans. 1 1998, 54,
371. (h) Schuster, M.; Blechert, S. Angew. Chem. Int. Ed.
1997, 36, 2036. (i) Grubbs, R. H.; Miller, S. J.; Fu, G. C.
Acc. Chem. Res. 1995, 28, 446. (j) Grubbs, R. H.; Chang, S.
Tetrahedron 1998, 54, 4413.
(13) (a) Maier, M. E.; Bugl, M. Synlett 1998, 1390.
(b) Sambasivarao, K.; Manivannan, E.; Ganesh, T.;
Sreenivasachary, N.; Ashoke, D. Synlett 1999, 1618.
(14) Araki, S.; Katsumura, N.; Ito, H.; Butsugan, Y. Tetrahedron
Lett. 1989, 30, 1581.
(15) General Procedure for the Indium-mediated allylation:
A mixture of anhydride (1 mmol) and Indium (2 mmol) in
anhyd DMF (2 mL) was added allylbromide (3 mmol) in
DMF (1 mL) and the reaction mixture was stirred at r.t. for
1 h. After complete conversion as indicated by TLC, aq
NH4Cl was added and the product was extracted with Et2O
(3 10 mL). The combined organic layers were washed with
brine, dried over anhyd Na2SO4 and concentrated in vacuo to
yield crude product, which was purified by column
chromatography using silica. The products 5a–e were
characterized by their IR and 1H NMR spectral data.
General procedure for the preparation of the
83%
87%
52%
92%
90a%
71%
64%
57%
80%
83a%
b
c
d
e
spirolactones (7a–e)using RCM: To a solution of the
ruthenium carbene catalyst 6 (5 mol%) in anhyd CH2Cl2
(1 mL) was added a solution of the diallyl compound
(5a–e) (50 mg) in anhyd CH2Cl2 (1 mL). The resulting
reaction mixture was stirred at r.t. for 1 h under N2
atmosphere. After complete conversion as indicated by
TLC, the solvent was removed in vacuo and the residue
purified by silica column chromatography and eluting with
EtOAc–Hexane (4:96) to give analytically pure products
(7a–e).
a Mixture of products were formed in 1:1 ratio.
Spectroscopic data: 5a: 1H NMR (200 MHz, CDCl3) 2.03
(t, 2 H, J = 7.5 Hz, -CH2), 2.28–2.45 (m, 4 H), 2.50 (t, 2 H,
J = 7.5 Hz, -CH2), 5.10–5.28 (m, 4 H, HC=CH2), 5.65–5.90
(m, 2 H, HC=CH2). 7a: 1H NMR (200 MHz, CDCl3) 2.20
(t, 2 H, J = 4.9 Hz, -CH2), 2.45 (d, 2 H, J = 9.8 Hz), 2.50 (t,
2 H, J = 4.9 Hz, -CH2), 2.75 (d, 2 H, J = 9.8 Hz), 5.62 (s, 2
H, HC=CH). MS: m/z (%) = 138 (M+), 110, 95, 83, 77, 55,
39. 5b: 1H NMR (400 MHz, CDCl3) 2.42–2.58 (m, 4 H),
5.10–5.20 (m, 4 H, HC=CH2), 5.60–5.70 (m, 2 H, HC=CH2),
6.05 (d, 1 H, J = 8.1 Hz, -CH=CH-), 7.25 (d, 1 H, J = 8.1 Hz,
-CH=CH-). 7b: 1H NMR (200 MHz, CDCl3) 2.70 (s, 4 H,
-CH2), 5.80 (s, 2 H, HC=CH), 6.02 (d, 1 H, J = 5 Hz, -
CH=CH-), 7.40 (d, 1 H, J = 5 Hz, -CH=CH-). 5c: 1H NMR
(200 MHz, CDCl3) 1.55–1.70 (m, 4 H), 2.45–2.49 (m, 4 H,
-CH2), 2.51–2.54 (m, 4 H), 5.01–5.52 (m, 4 H, HC=CH2),
5.82–6.05 (m, 2 H, HC=CH2). 7c: 1H NMR (200 MHz,
CDCl3) 1.48–1.60 (m, 4 H), 2.20–2.30 (m, 4 H, -CH2),
2.42–2.55 (m, 4 H), 5.68 (s, 2 H, HC=CH). 5d: IR (KBr):
1760 cm–1, 1H NMR (200 MHz, CDCl3) 2.61–2.66 (dd,
References and Notes
(1) IICT Communication No. 4858
(2) Geisler, J.; Cleve, A.; Harre, M. Tetrahedron 2000, 56,
6489.
(3) Grob, J.; Boillaz, M.; Schmidlin, J.; Wehrli, H.; Wieland, P.;
Fuhrer, H.; Rihs, G.; Joss, U.; Gasparo, M. D.; Haenni, H.;
Ramjoue, H. P.; Whitebread, S. E.; Kalvoda, J. Helv. Chim.
Acta. 1997, 80, 566.
(4) Graul, A. I. Drug News & Perspectives 2001, 14(1), 12.
(5) (a) Cella, J. A.; Tweit, R. C. J. Org. Chem. 1959, 24, 1109.
(b) Twiet, R. C.; Colton, F. B.; Mc Niven, N. L.; Klyne, W.
J. Org. Chem. 1962, 27, 3325.
(6) Rabasseda, X.; Silvestre, J.; Castañer, J. Drugs of the Future
1999, 24(5), 488.
(7) (a) Zhang, W.; Pugh, G. Tetrahedron Lett. 1999, 40, 7595.
(b) Zhang, W. Tetrahedron Lett. 2000, 41, 2523.
Synlett 2001, No. 11, 1787–1789 ISSN 0936-5214 © Thieme Stuttgart · New York